DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Irsogladine
Irsogladine
4 Supplementary File
Phosphodiesterase (PDE)
(12) United States Patent (10) Patent No.: US 8,716.252 B2 Schafer Et Al
Customs Tariff - Schedule
United States Patent 19 11 Patent Number: 5,446,070 Mantelle (45) Date of Patent: "Aug
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Proteostasis of Glial Intermediate Filaments: Disease Models, Tools, and Mechanisms
Assay Kits and Proteins for Drug Discovery
(12) Patent Application Publication (10) Pub. No.: US 2003/0068365A1 Suvanprakorn Et Al
(12) Patent Application Publication (10) Pub. No.: US 2004/0058896 A1 Dietrich Et Al
Large-Scale Transcriptional Profiling of Molecular Perturbations Reveals
Known Bioactive Library: Selleck Bioactive 10Mm, 3.33Mm, 1.11Mm
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Mitigation of NADPH Oxidase 2 Activity As a Strategy to Inhibit Peroxynitrite Formation
)&F1y3x PHARMACEUTICAL APPENDIX to THE
WO 2007/067570 Al
Customs Tariff - Schedule
FIG. 8B (57) Abstract: the Methods and Compositions Described Herein Relate to the Treatment of Fungal Infections, E.G
Top View
Pharmacology and Toxicology
Pharmaabkommen A1 E
)&F1y3x PHARMACEUTICAL APPENDIX to the HARMONIZED
Known Bioactive Library: Tocriscreen Mini Library 2
Bioactive Compound Library Plus (96-Well)
(PDE) Inhibitors
(12) Patent Application Publication (10) Pub. No.: US 2003/0059471 A1 Compton Et Al
Lack of Influence of Substrate on Ligand Interaction with the Human Multidrug and Toxin Extruder, MATE1 S
A Small Molecule Drug Screening Identifies Colistin Sulfate As an Enhancer of Natural Killer
Harmonized Tariff Schedule of the United States (2006) (Rev
Wo 2015/068142 A2
WO 2008/089148 Al
Supplementary Table 3
Figure 1 METHODS and COMPOSITIONS for the TREATMENT of DISORDERS ASSOCIATED with DEFECTS of the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE OR PROTEIN
Customs Tariff - Schedule
Pharmaceutical Ingredients for Research and Experimental Use
WO 2018/231759 Al 20 December 2018 (20.12.2018) W !P O PCT
WHO Drug Information
Harmonized Tariff Schedule of the United States (2006) (Rev